Praxis Precision Medicines, Inc.
PRAX
$305.00
$11.053.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 1,349.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 1,349.13% |
| Cost of Revenue | 37.70% | 57.10% | 131.13% | 125.34% | 206.11% |
| Gross Profit | -58.74% | -58.25% | -134.20% | -129.00% | -173.18% |
| SG&A Expenses | 29.13% | -17.66% | 23.39% | -9.20% | 52.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.88% | 37.14% | 101.00% | 76.59% | 152.18% |
| Operating Income | -51.74% | -37.87% | -102.91% | -78.41% | -130.01% |
| Income Before Tax | -51.52% | -42.43% | -117.67% | -75.20% | -118.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.52% | -42.43% | -117.67% | -75.20% | -118.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.52% | -42.43% | -117.67% | -75.20% | -118.32% |
| EBIT | -51.74% | -37.87% | -102.91% | -78.41% | -130.01% |
| EBITDA | -51.80% | -38.06% | -103.37% | -78.77% | -130.76% |
| EPS Basic | -19.16% | -22.38% | -90.80% | -15.70% | 0.99% |
| Normalized Basic EPS | -14.21% | -22.39% | -90.81% | -17.49% | -7.46% |
| EPS Diluted | -19.16% | -22.38% | -90.80% | -15.70% | 0.99% |
| Normalized Diluted EPS | -14.21% | -22.39% | -90.81% | -17.49% | -7.46% |
| Average Basic Shares Outstanding | 27.16% | 16.38% | 14.08% | 51.43% | 120.51% |
| Average Diluted Shares Outstanding | 27.16% | 16.38% | 14.08% | 51.43% | 120.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |